Company intelligence / Profile preview

Beijing Youfeng International Consulting

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing Youfeng International Consulting is a China-based consulting and project management firm that acted as project initiator and organizer for a joint entity in China to develop Generex's Ii-Key peptide vaccine platform for SARS-CoV-2 and other vaccines, but it is not itself the R&D sponsor or biotech platform owner.[4][7]

Industry: Consulting

Partnerships

Generex Biotechnology Corporation[4][7]NuGenerex Immuno-Oncology[4]National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention[4][7]Beijing Guoxin Haixiang Equity Investment Partnership[4][7]

Beyond the preview

Go deeper on Beijing Youfeng International Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Youfeng International Consulting.

Explore the full profile